UNSPSC 41141809: Fructosamine

In this classification, this entry connotes a substrate made of Fructosamine that is used in clinical chemistry testing.

UNSPSC 41141809 Fructosamine, a Commodity code, does not map to the state and local procurement opportunities recently posted under it. The code nominally describes a single clinical chemistry analyte, but recent solicitations tagged with this code overwhelmingly concern laboratory consumables and diagnostic reagents spanning genomic sequencing kits, pathogen detection panels, culture media, solid-phase extraction disks, chemical standards, and analytical spiking solutions — none of which are fructosamine assays or related to fructosamine testing. The mismatch suggests either systematic mis-tagging in state procurement systems or a broad interpretation of the code that extends far beyond its intended scope. The actual work being bought falls across multiple unrelated UNSPSC families covering molecular diagnostics, microbiology, chemistry, and laboratory equipment supply.

State and local health departments drive the recent activity, primarily the Texas Health and Human Services Commission (HHSC) on behalf of the Texas Department of State Health Services (DSHS), supplemented by the Mississippi State Department of Health, the University of Texas Health Science Center at San Antonio, the State of California, and the City of Philadelphia. Recent solicitations include HHSC IFBs for respiratory pathogen detection kits (HHS0017272, due May 19, 2026), culture media for foodborne pathogen testing (HHS0017132, due June 2, 2026), Atlantic ReadyDisk solid-phase extraction disks (HHS0017287, due May 13, 2026), gas chromatography consumables and chemical standards (HHS0017271, due May 12, 2026), and a Clear Dx sequencing instrument (HHS0016980, closed February 19, 2026); Mississippi pursued sole-source contracts for Clear Labs WGS reagents (due May 14, 2026, $226,072.00) and Illumina sequencing kits (due May 14, 2026, $393,667.98); the University of Texas Health Science Center at San Antonio issued an RFP for a comprehensive biotech research and clinical diagnostics equipment catalog (due June 4, 2026); and California solicited MyCodeDR mycobacterial reagents (due April 29, 2026) and Cerilliant certified spiking solutions (due April 13, 2026). Activity concentrates in Texas, with secondary volume in Mississippi and California. The code shows no meaningful recent activity aligned with fructosamine procurement and should not be relied upon for market intelligence in that analyte space.